Wegovy FlexTouch 1 mg 1 pre-filled pen
Novo Nordisk
Novo Nordisk
Overview
Wegovy FlexTouch 1 mg is a prescription injectable medicine containing semaglutide, supplied as a pre-filled pen by Novo Nordisk, indicated for chronic weight management and related cardiovascular risk reduction.
Key Benefits
Semaglutide is indicated for long-term weight management in adults with obesity or with overweight accompanied by a weight-related health condition, as well as for weight management in adolescents aged 12 and above with obesity. It is also indicated to reduce the risk of major adverse cardiovascular events in adults who have established cardiovascular disease together with obesity or overweight.
How to Use
Use as directed by your physician or pharmacist; administered by injection according to the prescribed schedule.
Active Ingredients
Semaglutide.
Precautions
For use under medical supervision only. Inform your doctor of any personal or family history of thyroid tumours, pancreatitis, or other relevant medical conditions before starting treatment. Not intended for use during pregnancy. Follow your prescriber's instructions closely and do not adjust the dose without medical advice.
Storage
Store refrigerated as indicated on the packaging; keep out of reach of children and away from light.